Behavioral Intervention for Sexual Dysfunction in Multiple Sclerosis
(BIPAMS-SD Trial)
Trial Summary
What is the purpose of this trial?
The prevalence of sexual dysfunction is higher among women with multiple sclerosis (MS) than women in the general population. The presence of sexual dysfunction is associated with decreased well-being and quality of life. There is limited research supporting pharmacological and other therapeutic approaches for managing sexual dysfunction in MS. Physical activity has beneficial effects on many of the consequences of MS, and physical activity represents a promising non-pharmacological approach for managing symptoms of sexual dysfunction in MS. The proposed research examines the effect of an Internet-delivered lifestyle physical activity intervention for improving sexual dysfunction in women with MS. The research proposed, if successful, will provide evidence for the efficacy of physical activity as a translatable approach for managing sexual dysfunction among women with MS.
Research Team
Eligibility Criteria
This trial is for women aged 18-45 with relapsing-remitting multiple sclerosis and sexual dysfunction, who are in a committed relationship. Participants must be able to walk without help, have low physical activity levels, internet access, speak English, and not be at risk of injury from exercise.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Behavioural intervention for physical activity for multiple sclerosis (BIPAMS) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Kierstin Kennedy
University of Alabama at Birmingham
Chief Medical Officer since 2022
MD
S. Dawn Bulgarella
University of Alabama at Birmingham
Chief Executive Officer since 2023
BSc in Commerce and Business Administration from the University of Alabama, MS in Health Administration from the University of Alabama at Birmingham
National Multiple Sclerosis Society
Collaborator
Dr. Tim Coetzee
National Multiple Sclerosis Society
Chief Executive Officer
PhD in Molecular Biology
Dr. Gertrude S. Carter
National Multiple Sclerosis Society
Chief Medical Officer since 2015
MD from Harvard Medical School